Table 2.
Mean outcome measures (with SD) and effect sizes * (Cohens’ d ) of the step-down and outpatient treatments at baseline and at 8, 18, 3, and 6- years of follow-up
|
Step-down | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 8 months | 18 months | 3- years | 6- years | d | ||||||
| GAF |
47.3 |
(4.3) |
51.5 |
(10.2) |
53.5 |
(10.3) |
57.7 |
(12.7) |
62.7 |
(13.6) |
1.92 |
| WSAS |
25.3 |
(7.2) |
20.6 |
(8.6) |
19 |
(9) |
19.2 |
(10.6) |
13.7 |
(11.0) |
1.19 |
| GSI |
1.71 |
(0.69) |
1.43 |
(0.65) |
1.32 |
(0.75) |
1.19 |
(0.75) |
0.91 |
(0.72) |
1.14 |
| BDI |
18.3 |
(8.2) |
17.2 |
(7.6) |
15.5 |
(10.7) |
14.7 |
(11.3) |
13,0 |
(11.2) |
0.56 |
| CIP |
1.66 |
(0.53) |
1.53 |
(0.59) |
1.51 |
(0.6) |
1.42 |
(0.62) |
1.13 |
(0.68) |
0.89 |
| QOL |
3.3 |
(1.6) |
4.5 |
(1.6) |
4.9 |
(2.1) |
5.4 |
(2) |
6.1 |
(2.3) |
1.49 |
| PDcrit |
13.3 |
(5.6) |
|
|
|
|
8.5 |
(6.4) |
5.9 |
(6.5) |
1.24 |
|
Outpatient | |||||||||||
| |
Baseline |
8 months |
18 months |
3- years |
6- years |
d
|
|||||
| GAF |
47.9 |
(4.6) |
50.2 |
(12) |
56.8 |
(11.7) |
66.9 |
(12.6) |
57.1 |
(14.5) |
1.10 |
| WSAS |
24.7 |
(8.2) |
18.9 |
(9.9) |
15.7 |
(11.2) |
12.6 |
(10.9) |
18.3 |
(11.3) |
0.68 |
| GSI |
1.75 |
(0.62) |
1.43 |
(0.73) |
1.23 |
(0.73) |
1.06 |
(0.79) |
1.12 |
(0.74) |
0.95 |
| BDI |
19.9 |
(9.5) |
18.5 |
(11.8) |
16.6 |
(12.5) |
12.2 |
(10.3) |
13.4 |
(9.95) |
0.66 |
| CIP |
1.72 |
(0.48) |
1.52 |
(0.57) |
1.25 |
(0.62) |
1.22 |
(0.64) |
1.32 |
(0.62) |
0.75 |
| QOL |
3.6 |
(1.7) |
4.4 |
(1.9) |
5.1 |
(2.3) |
5.9 |
(2.2) |
5.5 |
(1.85) |
1.08 |
| PDcrit | 13.4 | (4.8) | 6.0 | (5.8) | 5.6 | (5.6) | 1.53 | ||||
Note. GSI: Global Severity Index; GAF: Global Assessment of Functioning; CIP: Circumplex of Interpersonal Problems; BDI: Beck depression inventory; WSAS: Social and Adjustment Scale; QoL: Quality of Life. *Effect sizes (d) are pre-post estimates from baseline to 6- years of follow-up.